ArticleFrontiers in endocrinology2023

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib.

Yuanna Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.